Boston Scientific (BSX)
Builds minimally invasive devices for cardiovascular, endoscopic, urological and neuromodulation procedures.
$44.35
vs last close−0.58 (−1.28%)
Something off on this page? Send us feedback.
Next report
Oct 28, 26
in 35 days
EPS estimate
$0.79
Revenue estimate
$5.18B
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25Apr '25Jul '25Oct '25Feb '26Apr '26Jul '26Oct '26
Reported$0.70$0.75$0.75$0.75$0.80$0.80$0.86Pending
Estimate$0.66$0.67$0.73$0.71$0.78$0.79$0.84$0.79
Surprise+6.5%+11.4%+3.4%+5.0%+2.4%+1.5%+3.0%—
RevenueReportedEstimate
Feb '25Apr '25Jul '25Oct '25Feb '26Apr '26Jul '26Oct '26
Reported$4.56B$4.66B$5.06B$5.07B$5.29B$5.20B$5.44BPending
Estimate$4.42B$4.57B$4.89B$4.97B$5.28B$5.17B$5.38B$5.18B
Surprise+3.2%+2.0%+3.4%+1.9%+0.1%+0.6%+1.2%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2028 | $1.08 | — | — |
| Sep 2028 | $0.93 | — | — |
| Jun 2028 | $0.95 | — | — |
| Mar 2028 | $0.90 | — | — |
| Dec 2027 | $0.89 | — | — |
| Sep 2027 | $0.85 | — | — |
| Jun 2027 | $0.86 | — | — |
| Mar 2027 | $0.80 | — | — |
| Dec 2026 | $0.84 | — | — |
| Oct 2026 | $0.79 | — | — |
| Jul 2026 | $0.84 | $0.86 | +3.0% |
| Apr 2026 | $0.79 | $0.80 | +1.5% |
| Feb 2026 | $0.78 | $0.80 | +2.4% |
| Oct 2025 | $0.71 | $0.75 | +5.0% |
| Jul 2025 | |||
| Apr 2025 | |||
| Feb 2025 | |||
| Oct 2024 | |||
| Jul 2024 | |||
| Apr 2024 | |||
| Jan 2024 | |||
| Oct 2023 | |||
| Jul 2023 | |||
| Apr 2023 | |||
| Feb 2023 | |||
| Oct 2022 | |||
| Jul 2022 | |||
| Apr 2022 | |||
| Feb 2022 | |||
| Oct 2021 | |||
| Jul 2021 | |||
| Apr 2021 | |||
| Feb 2021 | |||
| Oct 2020 | |||
| Jul 2020 | |||
| Apr 2020 | |||
| Feb 2020 | |||
| Oct 2019 | |||
| Jul 2019 | |||
| Apr 2019 | |||
| Feb 2019 | |||
| Oct 2018 | |||
| Jul 2018 | |||
| Apr 2018 | |||
| Feb 2018 | |||
| Oct 2017 | |||
| Jul 2017 | |||
| Apr 2017 | |||
| Feb 2017 | |||
| Oct 2016 | |||
| Jul 2016 | |||
| Apr 2016 | |||
| Feb 2016 | |||
| Oct 2015 | |||
| Jul 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2028 | $1.08 | — | — | $6.47B | — | — | — |
| Sep 2028 | $0.93 | — | — | $5.98B | — | — | — |
| Jun 2028 | $0.95 | — | — | $6.07B | — | — | — |
| Mar 2028 | $0.90 | — | — | $5.79B | — | — | — |
| Dec 2027 | $0.89 | — | — | $5.71B | — | — | — |
| Sep 2027 | $0.85 | — | — | $5.52B | — | — | — |
| Jun 2027 | $0.86 | — | — | $5.62B | — | — | — |
| Mar 2027 | $0.80 | — | — | $5.35B | — | — | — |
| Dec 2026 | $0.84 | — | — | $5.44B | — | — | — |
| Oct 28, 2026 | $0.79 | — | — | $5.18B | — | — | — |
| Jul 29, 2026 | $0.84 | $0.86 | +3.0% | $5.38B | $5.44B | +1.2% | −0.0% |
| Apr 22, 2026 | $0.79 | $0.80 | +1.5% | $5.17B | $5.20B | +0.6% | +9.0% |
| Feb 4, 2026 | $0.78 | $0.80 | +2.4% | $5.28B | $5.29B | +0.1% | −17.6% |
| Oct 22, 2025 | $0.71 | $0.75 | +5.0% | $4.97B | $5.07B | +1.9% | +4.0% |
| Jul 23, 2025 | |||||||
| Apr 23, 2025 | |||||||
| Feb 5, 2025 | |||||||
| Oct 23, 2024 | |||||||
| Jul 24, 2024 | |||||||
| Apr 24, 2024 | |||||||
| Jan 31, 2024 | |||||||
| Oct 26, 2023 | |||||||
| Jul 27, 2023 | |||||||
| Apr 26, 2023 | |||||||
| Feb 1, 2023 | |||||||
| Oct 26, 2022 | |||||||
| Jul 27, 2022 | |||||||
| Apr 27, 2022 | |||||||
| Feb 2, 2022 | |||||||
| Oct 27, 2021 | |||||||
| Jul 27, 2021 | |||||||
| Apr 28, 2021 | |||||||
| Feb 3, 2021 | |||||||
| Oct 28, 2020 | |||||||
| Jul 29, 2020 | |||||||
| Apr 29, 2020 | |||||||
| Feb 5, 2020 | |||||||
| Oct 23, 2019 | |||||||
| Jul 24, 2019 | |||||||
| Apr 24, 2019 | |||||||
| Feb 6, 2019 | |||||||
| Oct 24, 2018 | |||||||
| Jul 25, 2018 | |||||||
| Apr 25, 2018 | |||||||
| Feb 1, 2018 | |||||||
| Oct 26, 2017 | |||||||
| Jul 27, 2017 | |||||||
| Apr 27, 2017 | |||||||
| Feb 2, 2017 | |||||||
| Oct 26, 2016 | |||||||
| Jul 28, 2016 | |||||||
| Apr 27, 2016 | |||||||
| Feb 4, 2016 | |||||||
| Oct 28, 2015 | |||||||
| Jul 23, 2015 |